| ER | Endoplasmic reticulum |
| GALNT | N-acetylgalactosaminyltransferase |
| GalNAc | N-acetylgalactosamine |
| FUT8 | α-(1,6)-fucosyltransferase |
| GLCNAc-TV or MGAT5 | N-acetylglucosaminyltransferase |
| GDP-β-l-fucose | Guanosine diphosphate |
| GMD | GDP-mannose 4,6-dehydrastase |
| FX protein | GDP-keto-6-deoxymannose 3,5-epimerase, 4-reductase |
| NADPH | Nicotinamide adenine dinucleotide phosphate |
| AFP | α-fetoprotein |
| HCC | Hepatocellular carcinoma |
| LCA | Lens culinaris agglutinin |
| PCa | Prostate Cancer |
| PSA | Prostate Specific Antigen |
| BPH | Benign Prostate Hyperplasia |
| HPLC | High-performance liquid chromatography |
| AAL | Aleuria aurantica lectin |
| AGP | α1-acid glycoprotein |
| CAIE | Crossed affinoimmunoelectrophoresis |
| fAGP | α1,3fucosylated AGP |
| RPN1 | Ribophorin I |
| FUTs | Fucosyltransferases |
| NSCLC | Nonsmall cell lung cancer |
| LEF-1 | Lymphoid enhancer binding factor 1 |
| CRC | Colorectal cancer |
| DFS | Disease free survival |
| EOC | Epithelial Ovarian Cancer |
| cDDP | Cisplatin |
| CTR1 | Copper transporter 1 |
| PrECs | Prostate epithelial cells |
| PrSCs | Prostate stromal cells |
| ADT | Androgen Deprivation Therapy |
| EV | Extracellular Vesicles |
| PDAC | Pancreatic ductal adenocarcinoma |
| ADCC | Antibody-dependent cellular cytotoxicity |
| PD-1 | Programmed cell death |
| TGF-β | Transforming growth factor- β1 |
| EGF | Epidermal growth factor |
| FcRs | Lymphocyte receptors |
| Fc | Constant region |
| IgG | Immunoglobulin G |
| CHO | Chinese hamster ovary |
| EMT | Epithelial-mesenchymal transition |
| E-box | Enhancer box |
| ZFNs | Zinc-finger nucleases |
| SGN-2FF | 2-fluorofucose |
| FDA | US Food and Drug Administration |
| NHL | Non-Hodgkin’s lymphoma |
| CTCL | T-cell lymphoma |
| HTLV1 | T-lymphotrophic virus 1 |